What are the benefits and risks of different treatments that could delay or slow the progression of progressive... 6a113x

There are more than 60 Cochrane Reviews relevant to multiple sclerosis and, one of these, a network meta-analysis of immunomodulators and immunosuppressants for progressive multiple sclerosis, was updated in September 2024. We asked one of the authors, sco Nonino from the Istituto delle Scienze Neurologiche di Bologna in Italy, to tell us about the condition and the latest evidence in this podcast. 622g1z